Cited by 101Gut microbiota and healthBirth, Development, and HealthInfant Nutrition and Health

Maternal modifiers of the infant gut microbiota: Metabolic consequences

Open access
Mulligan, Christopher M, Friedman, Jacob E·2017·Journal of Endocrinology

Abstract

Transmission of metabolic diseases from mother to child is multifactorial and includes genetic, epigenetic and environmental influences. Evidence in rodents, humans and non-human primates support the scientific premise that exposure to maternal obesity or high-fat diet during pregnancy creates a long-lasting metabolic signature on the infant innate immune system and the juvenile microbiota, which predisposes the offspring to obesity and metabolic diseases. In neonates, gastrointestinal microbes introduced through the mother are noted for their ability to serve as direct inducers/regulators of the infant immune system. Neonates have a limited capacity to initiate an immune response. Thus, disruption of microbial colonization during the early neonatal period results in disrupted postnatal immune responses that highlight the neonatal period as a critical developmental window. Although the mechanisms are poorly understood, increasing evidence suggests that maternal obesity or poor diet influences the development and modulation of the infant liver and other end organs through direct communication via the portal system, metabolite production, alterations in gut barrier integrity and the hematopoietic immune cell axis. This review will focus on how maternal obesity and dietary intake influence the composition of the infant gut microbiota and how an imbalance or maladaptation in the microbiota, including changes in early pioneering microbes, might contribute to the programming of offspring metabolism with special emphasis on mechanisms that promote chronic inflammation in the liver. Comprehension of these pathways and mechanisms will elucidate our understanding of developmental programming and may expand the avenue of opportunities for novel therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/joe-17-0303

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Jantscher-Krenn E Lauwaet T Bliss LA Reed SL Gillin FD Bode L 2012 Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro The British Journal of Nutrition 108 1839 1846 22264879

Cited by

Sorted by citations

Authors
Mulligan, C. M., & Friedman, J. E.
Affiliations
University of Colorado Anschutz (US)
Corresponding author
Friedman, Jacob E
Venue
Journal of Endocrinology
Published
2017-10-01
Volume
235
Issue
1
Pages
R1-R12
ISSN
  • 0022-0795 (ISSN-L)
  • 1479-6805
OpenAlex
W2739563526
Cited by
101
References
106
Citations by year
2026: 4 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 15 · 2020: 25 · 2019: 12 · 2018: 11
FWCI
1.23
Type
journal article
Language
en
Open access
Locations
  • Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (NIH-R01, DK048520)
  • Nutrition Obesity Research Center, University of North Carolina
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078590, P30DK048520)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
maternal obesity, maternal high-fat diet, infant gut microbiota, developmental programming, metabolic disorders, neonatal innate immunity, intestinal barrier integrity, offspring obesity risk
MeSH terms
Gastrointestinal Microbiome, Animals, Female, Humans, Infant, Metabolic Diseases, Pregnancy, Prenatal Exposure Delayed Effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review